eMed and Scripps partner to study viral rebound after Covid-19
The initial data from the study is anticipated to be available in the coming weeks.
Infectious Disease
Latest in
Infectious Disease
BerGenBio randomises first patient in Covid-19 treatment study
A lead candidate of the company, bemcentinib is an oral inhibitor of AXL.
Pipeline Moves: trial terminations in colorectal cancer, cardiovascular infections, and kidney injury
The Clinical Trials Arena team also reviews endpoint achievement in liver disease, and trial completions in metabolic syndrome and pouchitis.
By
The epidemiology of RSV changed in UK children during the pandemic
With the relaxation of Covid-19 measures in the UK, there is an ongoing risk that RSV cases will rise sharply…
By
Vir doses first subject in Phase II hepatitis D virus treatment trial
The company anticipates reporting the preliminary findings from the trial next year.
Adamis’ Phase II/III Covid-19 therapy trial fails to meet primary endpoint
Due to a lack of efficacy, the independent Data Safety Monitoring Board advised halting the trial early.
Moat reports initial Phase I data for intranasal Covid-19 vaccine
Moat has opened a financing round, with lead investor Cortado Ventures making the initial investment.
Excision doses first subject in Phase I/II HIV therapeutic trial
Assessing the safety and tolerability of EBT-101 in patients with an undetectable viral load on ART is the trial’s primary…